Feedback / Questions
sonelokimab (M1095) - Avillion, MoonLake Immunotherap
https://www.globenewswire.com/news-release/2026/05/10/3291475/0/en/moonlake-immunotherapeutics-announces-positive-outcome-from-its-final-pre-bla-meeting-with-the-u-s-fda-and-reports-first-quarter-2026-financial-results.html
May 10, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next